Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Psoriasissjukdom sätts i fokus vid FN:s generalförsamling: IFPA uppmanar till att höja statusen för psoriasissjukdom under FN:s högnivåmöten
  • USA - English
  • India - English
  • MEXICO - Spanish
  • BRAZIL - Portuguese
  • Japan - Japanese
  • Korea - 한국어
  • USA - Français
  • USA - Deutsch
  • USA - español
  • APAC - Traditional Chinese

IFPA - International Federation of Psoriasis Associations

News provided by

IFPA

Sep 11, 2025, 12:25 ET

Share this article

Share toX

Share this article

Share toX

STOCKHOLM, 11 september, 2025 /PRNewswire/ -- Den internationella organisationen International Federation of Psoriasis Associations (IFPA) sätter fokus på psoriasissjukdom vid UNGA 80 i New York, där världsledare förväntas anta en ny politisk deklaration om icke-smittsamma sjukdomar (NCDs), mental hälsa och välmående.

Kort sammanfattning:

Frida Dunger - Executive Director of IFPA credit: IFPA
Frida Dunger - Executive Director of IFPA credit: IFPA
United Nations Headquarters in New York Credit: UN
United Nations Headquarters in New York Credit: UN
Frida Dunger - Executive Director of IFPA credit: IFPA United Nations Headquarters in New York Credit: UN
  • Runt 60 miljoner människor världen över lever med psoriasissjukdom — en allvarlig, livslång icke-smittsam sjukdom som påverkar huden, leder och andra organ. Psoriasis ökar även risken för diabetes, övervikt, hjärt-kärlsjukdomar och depression.
  • Trots att Världshälsoorganisationen (WHO) 2014 antog en resolution som erkände psoriasis som ett allvarligt hälsohot, har utvecklingen i frågan varit långsam sedan dess. IFPA (International Federation of Psoriasis Associations) uppmanar nu till ett starkare globalt engagemang.
  • IFPA-representanter reser till FN:s högnivåmöte om icke-smittsamma sjukdomar (NCDs) för att förespråka att personer med psoriasissjukdom inkluderas i globala och nationella hälsopolitiska ramverk, med särskilt fokus på att inkludera dem som lever med sjukdomen och låta dem vara med och utforma globala och nationella policyer.

Läs mer om eventet och registrera dig: https://pages.devex.com/devex-at-unga-80

Fulltext :

Psoriasissjukdom är en livslång, systemisk inflammatorisk sjukdom som ofta samexisterar med andra icke-smittsamma sjukdomar som diabetes, fetma, hjärt-kärlsjukdomar och depression. Ungefär 60 miljoner människor lever med denna sjukdom globalt. Trots detta förbises ofta psoriasissjukdom i hälsosystem världen över.

Den första och hittills enda resolutionen om psoriasis antogs av WHO 2014, där sjukdomen erkändes som ett stort hälsohot. Sedan dess har utvecklingen varit begränsad. IFPA kräver nu ett förstärkt globalt åtagande för att säkerställa att behoven hos personer med psoriasissjukdom integreras i både globala och nationella hälsopolicyer.

I samband med denna uppmaning reser IFPA-representanter till New York för att delta i FN:s högnivåmöte om icke-smittsamma sjukdomar (NCDs) i FN:s högkvarter den 25 september. Eventet samlar hälsoledare, experter och beslutsfattare för att forma framtiden för förebyggande och vård av icke-smittsamma sjukdomar. IFPA ser detta som en möjlighet att förespråka för mer inkluderande policyer, bättre tillgången till vård och större erkännande av psoriasissjukdom inom den bredare NCD-agendan.

Som en del i detta initiativ organiserar IFPA i samarbete med Devex ett panelsamtal i samband med UNGA, med titeln: Psoriatic Disease and NCDs: Putting Lived Experience at the Heart of Policy. Eventet hålls på Devex NCD Pavilion i Bryant Park i New York den 22 september.

Mer om eventet och registrering: https://pages.devex.com/devex-at-unga-80

I panelsamtalet medverkar Frida Dunger, IFPAs VD, och Kate Reynolds, IFPA-ambassadör som själv lever med psoriasissjukdom. Under samtalet delar Frida Dunger och Kate Reynolds med sig av sina perspektiv – om varför den som lever med psoriasissjukdom måste få en röst i det globala hälsopolitiken.

"Vi, personer som lever med psoriasissjukdom är mer än vår diagnos – vi är hela människor, och vi vill leva våra bästa liv, precis som alla andra. Jag reser till New York för att tala om psoriasis vid det här eventet för jag tror starkt på att inga beslut om oss ska fattas utan oss," delar Kate Reynolds, IFPAs ambassador.

"Inkluderande hälsopolitik är inte valfri, den är avgörande för att säkerställa att 60 miljoner människor världen runt som lever med psoriasissjukdom ska inte bli lämnade utanför," säger Frida Dunger, VD för IFPA.

Om IFPA

IFPA – IFPA (International Federation of Psoriasis Associations) är en global paraplyorganisation för nationella och regionala psoriasisföreningar. Organisationen grundades 1971 och har sitt huvudkontor i Stockholm, Sverige. IFPA arbetar för att förbättra livskvaliteten och tillgången till vård för personer som lever med psoriasis och psoriasisartrit. Organisationen samlar patientföreningar från hela världen för att driva frågor om vård, forskning, utbildning och opinionsbildning kring psoriasis. IFPA arrangerar internationella konferenser, bland annat World Psoriasis & Psoriatic Arthritis Conference och samarbetar med WHO och andra globala aktörer.

Läs mer: https://www.ifpa-pso.com/

Bild - https://mma.prnewswire.com/media/2771187/Frida_Dunger.jpg
Bild - https://mma.prnewswire.com/media/2771188/United_Nations_Headquarters_New_York.jpg
Logotyp - https://mma.prnewswire.com/media/2771186/IFPA_Logo.jpg

 

 

 

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Journée mondiale du psoriasis 2025 : L'IFPA appelle à stopper l'effet domino du psoriasis

Journée mondiale du psoriasis 2025 : L'IFPA appelle à stopper l'effet domino du psoriasis

Chaque année, le 29 octobre, la communauté mondiale marque la Journée mondiale du psoriasis, sensibilisant et se montrant solidaire avec plus de 60...

Día Mundial de la Psoriasis 2025: La IFPA hace un llamamiento para detener el efecto dominó de la psoriasis

Día Mundial de la Psoriasis 2025: La IFPA hace un llamamiento para detener el efecto dominó de la psoriasis

Cada año, el 29 de octubre, la comunidad internacional conmemora el Día Mundial de la Psoriasis, concientizando y solidarizándose con más de 60...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Mental Health

Mental Health

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.